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Mediators of monocyte migration, complement receptor-3 (CR3), and chemokine ligand-4 (CCL4) were measured in response to
recoverymodalities following resistance exercise.Thirty resistance-trainedmen (23.1±2.9 y; 175.2±7.1 cm; 82.1±8.4 kg) were given
neuromuscular electric stimulation (NMES), cold water immersion (CWI), or control (CON) treatments immediately following
resistance exercise. Blood samples were obtained preexercise (PRE), immediately (IP), 30 minutes (30 P), 24 hours (24H), and 48
hours (48H) after exercise for measurement of circulating CCL4 and CR3 expression on CD14+ monocytes, by assay and flow
cytometry. Circulating CCL4 showed no consistent changes. Inferential analysis indicated that CR3 expression was likely greater in
CON at 30 P than NMES (90.0%) or CWI (86.8%). NMES was likely lower than CON at 24H (92.9%) and very likely lower at 48H
(98.7%). Expression of CR3 following CWI was very likely greater than CON (96.5%) at 24H.The proportion of CR3+ monocytes
was likely greater following CWI than NMES (85.8%) or CON (85.2%) at 24H.The change in proportion of CR3+ monocytes was
likely (86.4%) greater following NMES than CON from IP to 30 P. The increased expression of CR3 and increased proportion of
CR3+monocytes following CWI at 24H indicate a potentially improved ability formonocyte adhesion to the endothelium, possibly
improving phagocytosis of damaged tissues.
1. Introduction
Skeletal muscle damage resulting from resistance exercise
stimulates an inflammatory cascade initiated by cytokines [1].
In addition to the increases in markers of muscle damage
like creatine kinase (CK) and myoglobin, the inflammatory
responses to resistance exercise includes, amongmany others,
increases in tumor necrosis factor-𝛼 (TNF-𝛼), interleukin-
10 (IL-10), and C-reactive protein (CRP) [1–4]. During the
inflammatory process, the cell adhesion molecule comple-
ment receptor 3 (CR3), consisting of the integrin molecules
cluster of differentiation (CD)11b and CD18 [5], facilitates
monocyte vascular adhesion andmigration into the damaged
tissue, thereby promoting phagocytosis of opsonized parti-
cles [5, 6]. Prior to extravasation, monocytes are signaled
to the site of inflammation, primarily through chemotaxis
[7]. During chemotaxis, several chemokines are secreted,
including macrophage inflammatory protein-1𝛽, also known
as chemokine ligand 4 (CCL4) [8].While the actions of CCL4
and CR3 on leukocytes are not fully understood, previous
research has shown increases in CCL4 concentration [9] and
CR3 expression following exercise [10]. Many other studies,
however, have found equivocal results [11–13]. Additionally,
whether these processes can be altered by athletic training
therapies following muscle damaging exercise is presently
unknown.
Cold water immersion (CWI) therapy is a common
recovery modality utilized to assist athletes in recovery from
high intensity exercise [14]. CWI can alleviate delayed onset
muscle soreness (DOMS) and reduce the efflux of creatine
kinase (CK) up to 48 hours following exercise [14]. CWI has
also been demonstrated to decrease postexercise leukocytosis
or increase the number of leukocytes, specifically, polymor-
phonuclear cells and lymphocytes, in response to muscle
damage [15, 16]. CWI has been demonstrated to modulate
cytokine and chemokine activity [4, 17], while cold exposure
in vitro has shown to increase the expression of cell adhe-
sion molecules, specifically the 𝛽2-integrin CD11b/CD18, on
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cultured neutrophils [18], which may mediate phagocytic
migration [5]. However, in vivo examination of the influence
of CWI on the processes of monocyte cell adhesion is yet to
be demonstrated.
Neuromuscular electrical stimulation (NMES) is another
recovery modality intended to increase blood flow to the
inflamed tissue [19, 20]. Despite the minimal benefits to
strength and power recovery [19, 21], NMESmay be beneficial
for removal of metabolic waste [22] and reducing circulating
levels of CK [21]. Recent work from our lab has indicated that
the use of NMES suppressed the natural increase in TNF-
𝛼 receptor-1 on monocytes 30 minutes after exercise which
remained for 48 hours following an acute heavy resistance
training bout [3], indicating a modulation of the immune
response. However, howNMES potentially intervenes during
the postexercise monocyte cell adhesion cascade is yet to be
determined.
Investigation of the expression of CR3 on monocytes
and concomitant circulating concentrations of CCL4 during
recovery from muscle damaging exercise will help us to
better understand the processes andmechanisms of exercise-
induced muscle damage and subsequent repair. Additionally,
examining how recoverymodalitiesmediate the cell adhesion
response may provide specific evidence supporting various
strategies used to facilitate recovery. To our knowledge, this
will be the first study to examine the impact of a dynamic
strength training session on CCL4 and CR3. Therefore, the
purpose of this study was twofold. First, we examined the
circulating CCL4 and CR3 responses to acute high volume
resistance exercise. Secondly, we examined the influence of
two recoverymethods (NMES andCWI) following resistance
exercise on the concentration of the chemokine CCL4 and
expression and proportion of CR3+ cells.
2. Methods
2.1. Participants. Thirty resistance-trainedmales volunteered
to participate in this study. Participants were randomly
divided into three treatment groups: control (CON) (𝑛 = 10),
neuromuscular electrical stimulation (NMES) (𝑛 = 10), and
cold water immersion (CWI) (𝑛 = 10). Subjects’ charac-
teristics are depicted in Table 1. Following an explanation of
all procedures, risks, and benefits, each participant gave his
written informed consent prior to participation in this study.
The Institutional ReviewBoard of the university approved the
research protocol. For inclusion in the study, participants had
to have a minimum of one year of resistance training experi-
ence, particularly in the squat exercise. Participants were not
permitted to use any additional nutritional supplements or
medications while enrolled in the study. Screening for nutri-
tional supplements and performance enhancing drug use was
accomplished via a health history questionnaire completed
during participant recruitment. Participants were instructed
not to partake in any additional recovery strategies while
enrolled in the study including NSAIDs, saunas, stretching
routines, foam rollers, massages, and additional hot/cold
water therapy.
Table 1: Subject characteristics.
NMES CWI CON
𝑛 10 10 10
Age (y) 23.0 ± 3.0 22.5 ± 3.0 23.8 ± 3.0
Height (cm) 175.9 ± 7.6 171.4 ± 6.6 178.3 ± 5.6
Weight (kg) 83.5 ± 9.8 77.1 ± 7.7 85.7 ± 5.4
BMI 27.0 ± 2.55 26.5 ± 2.13 27.0 ± 2.44
Descriptive characteristics of participants in neuromuscular electrical stim-
ulation (NMES), cold water immersion (CWI), and control (CON).
2.2. Study Protocol. Participants reported to the Human
Performance Laboratory (HPL) on four separate occasions.
On the first visit (T1), participants were tested for maximal
strength (1-RM) on the barbell back squat, dead lift, and
barbell split squat exercises. Prior to the second visit (T2),
which occurred at least 72 hours after T1, participants were
instructed to refrain from all forms of exercise for aminimum
of 72 hours. Also, prior to subsequent exercise sessions,
participants were instructed to report to the HPL in a 10-
hour fasted state. During T2, participants performed a lower
body resistance exercise session which consisted of four sets
of the squat, dead lift, and barbell split squat exercises. The
rest interval between each set and between all exercises was
90 s. The squat exercise was performed with 80% of the
participant’s previously measured 1-RM, while the dead lift
and barbell split squat exercises were performed with 70%
of the participant’s previously measured 1-RM. Participants
were encouraged to perform as many repetitions as possible,
but not to exceed 10 repetitions in any set. This protocol
was utilized to simulate a typical high intensity lower body
training routine during a hypertrophy phase of training.
Participants then reported back to the HPL 24 (T3) and 48
hours (T4) after exercise. During T3 and T4, participants
performed four sets of the squat exercise only using the same
loading pattern and rest interval length as T2 to monitor
strength and power. Participants were asked to complete
dietary logs during the two days of recovery. Blood samples
were obtained at five time points over the course of the study:
baseline (BL), immediately after exercise (IP), and 30min
after exercise (30 P) during T2 and 24 (prior to exercise on
T3) and 48 hours (prior to exercise on T4) after T2 (24H and
48H, resp.). All trials started between 7 and 9 AM with each
individual starting at the same time of day.This allowed blood
samples obtained prior to exercise to be collected within 15
minutes of the previous day.
2.3. Neuromuscular Electrical Stimulation Therapy (NMES).
Participants assigned to NMES were provided with 24
minutes of electrical stimulation immediately following the
postexercise blood draw (T2) or after exercise (T3) using
a commercially available product. All treatments were pro-
vided according to the manufacturer’s instructions (Compex
Performance US, DJO, Vista, CA). Briefly, the participant
was placed in a supine position with three electrodes placed
on each of the quadriceps. Specifically, one large electrode
with a negative charge was placed at the most proximal point
of the upper leg, while two small electrodes with positive
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charge were placed on the belly of the vastus lateralis and
vastus medialis. The unit was set to an established recovery
mode, while the participants were asked to increase the
stimulation intensity to the highest possible level without
undue discomfort. The research team observed the partic-
ipants during stimulation to assist with proper intensity of
stimulation while also recording the stimulation setting as
previously noted [23]. The treatment protocol consisted of
nine sequences, with the first three stages lasting for two
minutes and the remaining six for three minutes. Frequency
of contraction started at 9Hz, stepping down 1Hz per stage
to 1Hz. The participants were asked to remain in a supine
position throughout the 24 minutes of treatment.
2.4. Cold Water Immersion (CWI). The participants in CWI
were required to fully immerse their lower body into a metal
tub (58.4 cm × 121.9 cm) filled to 22.9 cm of height with ice
water at 10∘–12∘C immediately following postexercise blood
draw (T2) or immediately after exercise (T3). Participants
sat in the water up to their umbilicus for 10 min. Once the
participants completed the 10 minutes in the ice bath they
were asked to remain in theHPL for an additional 20minutes
to ensure a similar postexercise intervention opportunity
with NMES and CON, who remained in the HPL for 30
minutes in a supine position.
2.5. Blood Measurements. During T2, PRE blood samples
were obtained following a 15 min equilibration period.
Additional blood samples were also drawn at IP and 30 P. All
blood samples were obtained using a Teflon cannula placed
in a superficial forearm vein using a three-way stopcock with
a male luer lock adapter. The cannula was maintained patent
using an isotonic saline solution (BectonDickinson, Franklin
Lakes, NJ). IP blood samples were taken within 1 minute of
exercise cessation. Following the resistance exercise protocol,
participants remained in the supine position for the full 30
min recovery phase prior to the 30 P blood sample being
drawn, except for the participants in the CWI groups, who
spent the first 10minutes of the 30minutes in the ice bath. All
T2 blood samples were drawn with a plastic syringe while the
participant was in a supine position. During T3 and T4, only
preexercise blood samples were drawn (24H and 48H, resp.)
following a 15 min equilibration period.These blood samples
were obtained from an antecubital arm vein using a 20-gauge
disposable needle equipped with a Vacutainer tube holder
(Becton Dickinson, Franklin Lakes, NJ). Blood samples of
each participant were obtained at the same time of day during
each session.
All blood samples were collected into two Vacutainer
tubes, one containing no anticlotting agent and the second
containing K
2
EDTA. A small aliquot of whole blood was
removed from the second tube and used for determination
of hematocrit and hemoglobin. The blood in the first tube
was allowed to clot at room temperature for 30 minutes
and subsequently centrifuged at 3,000×g for 15min along
with the remaining whole blood from the second tube. The
resulting plasma and serum were placed into separate 1.6-mL
microcentrifuge tubes and frozen at −80∘C for later analysis.
2.6. Cell Staining. Samples were obtained from fresh, antico-
agulated (K
2
EDTA) whole blood and analyzed in duplicate.
Erythrocytes were first lysed from 350 𝜇L of whole blood
with BD Pharm Lyse solution (BD Biosciences, Franklin
Lakes, NJ) within 30min of collection. Samples were then
washed in staining buffer containing 1 x phosphate-buffered
saline containing fetal bovine serum (BD Pharminigen Stain
Buffer; BD Biosciences) by centrifugation and aspiration
three times. Leukocytes were then resuspended in 100𝜇L BD
Pharminigen Stain Buffer. Direct stainingmethods were used
to label CR3 and CD14. Allophycocyanin (APC) conjugated
anti-CR3 (D12; BD Pharminigen) and PerCP Cy5.5 conju-
gated anti-CD14 (M5E2; BD Pharminigen) were used in the
receptor labeling process. Surface staining was performed by
adding 20𝜇L of directly conjugated APC-anti-CR3 and 5 𝜇L
of directly conjugated PerCP Cy5.5-anti-CD 14 to the cell
suspension and incubating in the dark for 30min at 20∘C.
Cells were resuspended in 1.0mL of stain buffer for flow
cytometry analysis.
2.7. Flow Cytometry. Flow cytometry analysis of stained cells
was run on a BDC6Accuri FlowCytometer (BDBiosciences,
San Jose, CA), equipped with BD Accuri analysis software
(BD Biosciences). Forward and side scatter along with two
fluorescent channels of data were collected using two lasers
providing excitation at 488 and 640 nm. Monocytes were
determined by initial gating based on forward and side
scatter, followed by gating for CD14+ cells as also described
by Tallone and colleagues [24]. A minimum of 10,000 events,
defined as CD14+ monocytes, was obtained with each sample
(Figure 1).
Analysis of monocyte subpopulations was completed by
quadrant analyses, in which CD14 was compared with CR3.
Mean fluorescence of CR3 on CD14+ cells was recorded,
representing the expression of CR3 per cell [25]. Proportion
of CR3+/CD14+ versus CR3−/CD14+ were determined by
quadrant analysis (Figure 1). Compensation for fluorescence
spillover was set based on manufacturer recommendations
(BD Biosciences).
2.8. Biochemical Analysis. Circulating levels of chemokine
(C-C motif) ligand 4 (CCL4), also referred to as macro-
phage inhibiting protein-1𝛽, were assessed by Magpix
(EMD Millipore, Billerica, MA, USA) via the human cyto-
kine/chemokine panel one (EMD Millipore, Billerica, MA,
USA). Samples were analyzed according to manufacturer’s
guidelines with an average coefficient of variation 6.25%.
Creatine kinase (CK) was analyzed with the use of
a spectrophotometer and a commercially available enzy-
matic kit (Sekisui Diagnostics, Charlottetown, PE, Canada)
per manufacturer’s instructions. Determination of serum
immunoreactivity values was determined using a BioTek
Eon spectrophotometer (BioTek, Winooski, VT, USA). To
eliminate interassay variance, all samples for a particular
assay were thawed once and analyzed in the same assay run
by a single technician. All samples were run in duplicate with
a mean intra-assay variance of 2.99%.
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Figure 1: Gating procedures for CD14+ cells. (a) CD14+ cells
selected from the specified region based on forward (FSC) and side
scatter (SSC) properties. (b) Two-dimensional histogram displaying
fluorescence characteristics of cells in selected region. Cells positive
for CR3 and CD14 are displayed in the upper right quadrant.
2.9. Dietary Logs. Participants were instructed to record
as accurately as possible everything they consumed during
workout days T2 and T3. Participants were instructed not to
eat or drink (except water) within 10 hours of reporting to
the HPL for subsequent visits. FoodWorks Dietary Analysis
software (McGraw Hill, New York, NY) was used to analyze
the dietary recalls for total kilocalorie intake (kcal) and
macronutrient distributions (carbohydrate, protein, and fat).
2.10. Statistical Analysis. All biochemical changes were
analyzed using a repeated measures analysis of variance
(ANOVA). Pairwise comparisons with the Bonferroni adjust-
ment were employed for significant main effects, while a
Tukey post hoc test was employed for significant interactions.
Prior to analysis all data were assessed to ensure normal dis-
tribution, homogeneity of variance, and sphericity. Changes
in dietary composition were analyzed using repeated mea-
suresANOVA.Results were considered significant at an alpha
level of 𝑃 ≤ 0.05. All data are reported as mean ± SD.
The effects of treatment modalities were analyzed using
magnitude-based inferences calculated from 90% confidence
intervals, as previously described by Batterham and Hopkins
[26]. Magnitude based inferences are a statistical approach to
data analysis which uses within-subject modeling as opposed
to combining data into a single unit of change as with
repeated measures. Magnitude based inferences have also
been used previously in conjunction with null hypothesis
testing [2, 4, 27] to allow for more sensitive interpretation,
providing more practically applicable understandings of the
results. Additionally, magnitude based inferences help deter-
mine whether a significant 𝑃 value is meaningful, as signifi-
cant 𝑃 values have been determined to be trivial previously
[27]. Absolute values and changes from IP were analyzed
to assess differences between groups at each individual time
point and across time, respectively. The IP time point was
selected as the initial baseline as no recovery methods had
been employed prior to IP. These values were then analyzed
via a published spreadsheet [28], with the smallest nontrivial
change set at 20% of the grand standard deviation [26].
All data are expressed with percent chances of a beneficial,
trivial, and negative outcome. Qualitative inferences, based
on quantitative chances were assessed as<1% almost certainly
not, 1–5% very unlikely, 5–25% unlikely, 25–75% possibly, 75–
95% likely, 95–99% very likely, and >99% almost certainly
[29].
3. Results
Groups did not differ in baseline physical characteristics.
Average resistance training experience was 6.5 ± 3.5 years,
and participants had an average squat 1RM of 151.0±31.0 kg.
No group differences were noted in the quantity of repetitions
performed, markers of muscle damage (CK) 24 and 48 hours
after exercise, or macronutrient composition on T2 and T3.
Decreases in repetitions from T2 (23.1–27.9) were noted for
all groups combined at T3 (−30%; 14.1–20.9) and T4 (−24%;
15.9–21.8). Additionally, increases in CK concentrations from
PRE (103.4–166.3 U/L) were observed at 24H (290%; 468.9–
677.1 U/L) and 48H (272%; 424.6–612.5 U/L). Performance
and nutritional data along with plasma volume shifts have
been previously reported [2]. Results have not been corrected
for plasma volume shifts.
3.1. CCL4 Concentration. No significant difference occurred
between groups at IP (𝑃 = 0.393). Additionally, no significant
main effect for time (𝑃 = 0.317) was observed. Magnitude
based inferences indicate that NMES was likely greater than
CON at IP (percent chance: 80.4%) and 24H (84.3%). CWI
was possibly greater than CON at IP (73.2%) and 24H
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Figure 2: CirculatingConcentration ofCCL4 (mean± SE). Changes
in CCL4 concentration before exercise (PRE), immediately after
exercise (IP), and 30 minutes (30 P), 24 hours (24H), and 48
hours (48H) after exercise in neuromuscular electrical stimulation
(NMES), cold water immersion (CWI), and control (CON) groups.
(a)The value is “likely” greater thanCON at the specified time point.
(b) The value is “possibly” greater than CON at the specified time
point.
(65.4%), while it was likely greater (77.7%) at 30 P. When
the change of values was assessed, the changes from IP were
possibly increased in NMES versus CON at 30 P (70.0%),
24H (52.5%), and 48H (65.6%). Additionally, changes from
IP were possibly increased in NMES compared to CWI at
24H (70.7%) and likely greater at 48H (82.7%). Changes
from IP to 24H and 48H were likely (83.6%) and possibly
(64.7%) trivial, respectively, when comparing CON to CWI
(Figure 2).
3.2. CR3 Expression (Reported as Mean Fluorescence) on
CD14+ Monocytes. Mean fluorescence intensity on CD14+
monocytes showed that no significant differences were
observed between groups at IP (𝑃 = 0.269); however, there
was a significant main effect for time (𝑃 = 0.004). Pairwise
comparisons indicate that CR3was elevated at 30 P compared
to PRE (𝑃 = 0.015), IP (𝑃 = 0.005), and 24H (𝑃 = 0.005)
(Figure 3).
Magnitude based inferences indicate that CR3 fluores-
cence onCD14+monocytes was likely lower followingNMES
than CON at IP (85.7%), 30 P (90.0%), and 24H (92.9%),
while it was very likely lower at 48H (98.7%). Additionally,
mean fluorescence following CWI was likely lower (86.8%)
than CON at 30 P, while it was very likely greater than
NMES at 24H (96.5%). Changes inCR3 expression onCD14+
monocytes were unclear for all time points and recovery
modalities (Figure 3).
3.3. Proportion of CR3+ Monocytes (CR3+/CD14+). No dif-
ference between groups at IP was observed (𝑃 = 0.690).
Additionally, only a trend for amain effect of time (𝑃 = 0.074)
was observed. Magnitude based inferences indicate that CWI
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Figure 3: Expression of the complement receptor 3 (CR3) on
CD14+ monocytes (mean ± SE). CR3 expression, as measured by
mean fluorescence intensity before exercise (PRE), immediately
after exercise (IP), and 30 minutes (30 P), 24 hours (24H), and 48
hours (48H) after exercise in neuromuscular electrical stimulation
(NMES), cold water immersion (CWI), and control (CON) groups.
(a) The value is “likely” lower than CON at the specified time point,
(b) the value is “very likely” lower than CON at the specified time
point, and (c) the value is “very likely” lower than CWI at the
specified time point.
resulted in a likely greater proportion of CR3+ monocytes
than NMES (85.8%) and CON (85.2%) at 24H (Figure 4).
Additionally, when changes from IP were analyzed, the
increase from IP to 30 P in proportion of CR3+ monocytes
was likely (86.4%) greater in NMES than CONwhile all other
analyses were unclear.
4. Discussion
The main findings of this investigation indicate that mean
florescence intensity expression of CR3 onCD14+monocytes
was elevated following an acute bout of heavy resistance
exercise. Recovery treatments appeared to affect both the
expression of CR3 and proportion of monocytes expressing
CR3. Postexercise treatments with NMES and CWI appeared
to attenuate the increased expression of CR3 observed in
CON. Additionally, NMES appears to reduce expression of
CR3 on CD14+ monocytes in comparison to both CWI
and CON at 24 and 48 hours after exercise. Conversely,
NMES likely increased the proportion of circulating CD14+
monocytes expressing CR3 immediately following treatment
compared to the control group. During recovery, CWI likely
resulted in a higher proportion of circulating CD14+ mono-
cytes expressing CR3 at 24H. Circulating CCL4 showed
large interindividual variation and did not appear to be
consistently affected by the exercise protocol or treatments.
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Figure 4: Proportion of CR3+/CD14+ monocytes (mean ± SE).
Changes in CR3 expression before exercise (PRE), immediately
after exercise (IP), and 30 minutes (30 P), 24 hours (24H), and 48
hours (48H) after exercise in neuromuscular electrical stimulation
(NMES), cold water immersion (CWI), and control (CON) groups.
(a) A “likely” lower value than CWI at the specified time point. (b)
A “likely” greater change from IP than CON at the specified time
point.
As CCL4 is a chemotactic cytokine responsible for the
recruitment of monocytes, natural killer cells, and other
immune cells, we had hypothesized that themuscle damaging
exercise would have resulted in significant elevations inCCL4
as part of the cell mobilization process. Similarly, we expected
changes in CCL4 response as a result of blood flow alterations
induced by the treatment modalities. However, contrary
to our hypothesis, circulating CCL4 did not appear to be
strongly influenced by exercise or treatment. While previous
research has shown circulating CCL4 to be elevated in
response to cardiovascular exercise [9], investigations using
resistance exercise similarly found no changes in circulating
CCL4 following eccentric leg extensions [11] and 3 × 6RM of
the squat, front squat, and leg extension exercise [13]. CCL4
production is stimulated by proinflammatory cytokines (e.g.,
TNF𝛼, IFN𝛾, and IL-1𝛽), while at the same time inhibited
by anti-inflammatory cytokines (e.g., IL-10) [8]. Since we
previously reported that TNF𝛼 and IL-10 were increased 30
minutes following this resistance exercise protocol [2, 4], it
is plausible that the interaction between these pro- and anti-
inflammatory factors may initiate competing signals leading
to the unclear result observed in this study.However, the large
interindividual variation in circulating CCL4 observed in our
study may have also masked any group trends in the data.
As CCL4 is a chemokine secreted by most immune cells [8],
large differences between individuals are expected and have
been previously demonstrated [30]. Future research should
further investigate the time course of CCL4 concentration
following resistance exercise and how it relates with pro- and
anti-inflammatory factors such as TNF𝛼 and IL-10.
CR3 expression significantly increased 30 minutes fol-
lowing heavy resistance exercise, which returned to baseline
levels approximately 24 hours later. Previous studies exam-
ining CR3 expression on monocytes in response to different
exercise protocols have found no increase in receptor expres-
sion immediately following exercise [10, 12] but have found
increases during the recovery period [10]. Nevertheless, the
timing of the expression of CR3 on circulating monocytes
appears to be controversial [10, 12]. As monocytes are a
primary source of proinflammatory cytokines following exer-
cise [1], their role in the subsequent inflammatory response
is essential. Typically, granulocytes migrate to the site of
inflammation within hours, while macrophages are observed
to increase in damaged tissue 24 hours following exercise
[31–34]. Monocytes are signaled to the site of inflammation
by chemotaxis and mediated by chemokines [7], which have
been demonstrated to increase following resistance or aerobic
exercise within one hour [9, 35], promoting the monocyte
response. One potential influence on CR3 expression is train-
ing status [36].The resistance-trained individuals recruited to
participate in the present study may have different response
patterns to the training stimulus as compared to nontrained
or recreationally active individuals used in previous inves-
tigations [10, 12]. It is possible that higher fitness level will
attenuate the monocytosis observed following exercise [13].
It is important to consider that although the present study
attempted to provide a unique timeline for CR3 expression
changes during 48 hours of recovery, changes could have
occurred between sampling periods that were not measured.
Further studies are needed to identify the time sequence of
CR3 expression in trained and untrained populations.
While both recovery modalities utilized in this study
appear to blunt the postexercise response in CR3 expression
on CD14+ monocytes at 30 P, NMES suppressed CR3 expres-
sion on CD14+ monocytes at 24 and 48 hours following the
initial exercise stimulus. To the best of our knowledge, no
prior studies have examined the expression of CR3 in vivo
or on monocytes following CWI. Nash and colleagues [18],
however, have previously demonstrated a gradual increase in
expression of CR3 when cultured neutrophils were cooled
to 10∘C in vitro. The contrasting results of this study may
be due to a different response in monocytes when cooled.
Alternatively, a reduced leukocytosis following CWI in vivo
[15] may explain the reduced expression of CR3 at 30 P
following CWI. During the postexercise period, monocyte
influx appears to occur with a high expression of CR3 [13,
16]. Our results indicate that CWI may reduce overall CR3
expression at 30 P by blunting the release of monocytes with
elevatedCR3 expression. It is important to note, however, that
a decreased leukocytosis following CWI is controversial [37],
and, to the best of our knowledge, no studies have examined
monocyte response following NMES. This emphasizes the
need for further research to determine the source and
impact of reduced expression of CR3 in monocytes following
treatment.
At 24H, we observed a likely greater proportion of CR3+
monocytes in CWI compared to NMES and CON. While
the proportion of CR3+ cells was consistent with previous
research [10], the difference observed following treatments is
a novel finding. As monocytes typically circulate for several
days [38], the increased proportion of CR3+ monocytes
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observed in this study at 24Hmay be a function of increased
expression, which may occur via multiple mechanisms.
Previously, it has been demonstrated that 20 minutes of
exposure to 10∘C in vitro nearly doubles the expression of
CR3 on granulocytes [18]. It is possible that this may also
occur with monocytes, leading to the observed increase
following CWI. Another potential mechanism is elevation of
C-reactive protein concentrations at 24 hours after exercise
[2] which has been demonstrated to upregulate CD11b and
CD18 [39], which together compose CR3 [5]. Interestingly,
the increases in CR3+ monocytes at 24H observed in this
study were not observed at 48H. While being speculative,
it is possible that the increased C-reactive protein may be a
more likely explanation as it followed the same time course
[2]. As IL-10 increases following cold exposure [2], another
potential mechanism would be IL-10 mediated expression
as IL-10 expression has been demonstrated to increase CR3
expression in an animal model [40]. Further research is
warranted to determine whether a greater proportion of
CR3+ cells, or simply CR3 expression, leads to increased
extravasation of monocytes and/or phagocytosis.
Additionally, the change in the proportion of
CR3+/CD14+ cells compared to CR3−/CD14+ cells from IP
to 30 P was likely greater in NMES versus CON.This increase
may be indicative of increased extravasation immediately
following NMES treatment. As NMES treatment increases
blood flow to inflamed tissue [19, 20], observed increases
in the proportion of CR3+ cells may be due to blood flow
changes. It is also possible that NMES affected proportion of
CR3+ cells via cytokine signaling. Recent work from our lab
has indicated that the use of NMES attenuated the increase
in TNF-𝛼 receptor 1 and IL-10 30 minutes following exercise
[2, 3]. Additionally, IL-10 may affect expression of CR3 on
monocytes by way of granulocyte colony stimulating factor
(G-CSF) [41, 42]. Future studies are needed to examine
the mechanisms of NMES during recovery, as well as CR3
expression at additional time points following the cessation
of treatment.
While this is the first study to report changes in adhe-
sion molecules on monocytes following different recovery
modalities after exercise induced muscle damage, several
considerations should be noted in the interpretation of
the results. The first consideration is the training status
of the participants. Resistance-trained men were recruited
for the study to ensure that participants could complete
the strenuous exercise protocol and to avoid potential risks
of implementing the protocol to untrained persons. While
recruitment criteria required that all participants have amini-
mum training experience of 1 year, there remains the potential
that the relative stress of the protocol varied by individual.
Secondly, the limitations of the blood sampling intervals
must be considered. Following the 30 P sampling time point,
there was almost 24 hours between blood samples. During
this 24-hour period, it is possible that inflammation from
muscle damage and anti-inflammatory effects of therapeutic
modalities may induce changes in cytokine and chemokine
concentrations that may influence CCL4 concentration and
adhesion molecules [12, 43]. Finally, while this investigation
sought to explainmechanisms underlying recovery specific to
CR3 and CCL4, it is important to keep in mind that several
other inflammatory cells and cytokines are involved in the
recovery process which may impact the actions of CD14+
monocytes. Future studies are needed to examine changes
in cell counts across more frequent sampling during the
recovery period with therapeuticmodalities and immune cell
measures.
In conclusion, expression of CR3 on CD14+ monocytes
was elevated following acute muscle damaging resistance
exercise implying an increased potential for each individual
cell to adhere to endothelial walls at 30minutes after exercise.
By 24 hours into recovery, the elevated expression of CR3
on CD14+ monocytes had returned to baseline. Treatment
with NMES appeared to attenuate the expression of CR3 on
CD14+monocytes during recovery up to 48 hours, indicating
a reduced potential for cellular endothelial adherence. Addi-
tionally, treatment with CWI likely increased the proportion
of CR3+ monocytes. Although we demonstrated exercise
and treatment influences on monocyte CR3 expression, the
subsequent impact of altered expression of CR3 or proportion
of CR3+ cells on extravasation and phagocytosis is not fully
understood.
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